Breezula (clascoterone) and Formula 82F (topical finasteride) are treatments for hairloss that block DHT differently; Breezula competes with DHT at the hormone receptor site without systemic effects, while 82F inhibits the enzyme that converts testosterone to DHT. Breezula may work for those who don't respond to finasteride and vice versa.
Dairy may contain DHT precursors that could affect hairloss and prostate health, with some users noting reduced hair shedding after eliminating dairy. Individual responses to dairy and DHT blockers vary, with some attributing hair health to diet changes and others seeing no impact.
PP405 is discussed as a potential adjunct therapy for hairloss, with skepticism about its effectiveness and trial results. Users mention combining it with finasteride and minoxidil for better results, while others debate the root causes of hairloss and the limitations of current treatments.
Minoxidil and finasteride are discussed for hairloss, with concerns about minoxidil's heart-related side effects. New treatments like PP405 are met with skepticism, often humorously noted as always being "five years away."
Finasteride is more effective for long-term hair maintenance by addressing the root cause of hairloss, while minoxidil acts as a growth stimulant with faster visible results. Combining both treatments is optimal, with oral minoxidil often showing better results for some individuals.
There is no imminent cure for hairloss, but treatments like Minoxidil, Finasteride, and new drugs such as KX-826, GT-20029, and PP405 are being explored. Current solutions focus on slowing hairloss and stimulating growth, with hopes for better options in the future.
Delayed release oral minoxidil is seen as a promising advancement for hairloss treatment, offering safer, higher doses and more consistent hair follicle stimulation compared to current options. However, it is not expected to replace finasteride or dutasteride, as it does not prevent androgenetic alopecia.
PP405 is being discussed as a potential hairloss treatment, possibly more effective than minoxidil. There are concerns about its effectiveness and product contamination, but some users report early signs of hair regrowth.
PP405 is a safer alternative to JXL069 for hairloss treatment because it penetrates the skin effectively and degrades in the blood, avoiding systemic toxicity. JXL069, when forced into the body, can cause dangerous side effects like lactic acidosis due to its inability to degrade safely.
Stem cell hair restoration lacks scientific evidence and is often considered a scam. Effective hairloss treatments include hair transplants, Minoxidil, and Finasteride, but stem cell treatments are not proven.
The conversation discusses using saw palmetto oil to reduce hairloss, with the user reporting decreased shedding but no regrowth yet. The user plans to try minoxidil and finasteride, noting previous success with minoxidil but concerns about its greasiness.
A young person struggling with hairloss switched from finasteride to 0.5mg dutasteride and Oral Minoxidil 2.5mg, hoping for improvement before graduation. They are considering a hair transplant and exploring other treatments like stemoxydine and hair fibers, while dealing with the emotional impact of early balding.
Clascoterone 5% topical solution shows promise for treating male-pattern hairloss by blocking DHT at the follicle without systemic absorption, potentially offering fewer side effects than oral treatments like finasteride. While results are promising, long-term safety and effectiveness need further study, and it may serve as a starting point for developing more effective treatments.
A user shared their experience with hairloss treatments, switching from 1mg finasteride and topical minoxidil to 5mg oral minoxidil and oral dutasteride, noting improvements despite shedding phases. Other users discussed the hair growth cycle, treatment effects, and shared advice on managing hairloss, including buzzing hair and maintaining mental health.
PP405 is a potential new hairloss treatment that works through metabolic pathways rather than hormonal ones, with an estimated market release between late 2027 and 2029. Current alternatives to finasteride include minoxidil, pyralutamide, fluridil, and RU58841, with hair transplants also being a viable option.
A 26-year-old is experiencing hairloss despite using minoxidil and dutasteride. Suggestions include shaving his head, trying oral minoxidil, or considering a hair transplant.
Procapil is marketed as a natural hairloss treatment but lacks strong evidence and is industry-biased. Minoxidil and Finasteride are the only FDA-approved treatments for androgenetic alopecia.
PP405 is a potential new hairloss treatment that might replace finasteride and minoxidil, but it is still in clinical trials and may not be available until 2028-2031. There is skepticism about its effectiveness, with only a 20% increase in hair density observed in some participants.
A young person is experiencing aggressive hairloss and not responding well to minoxidil and finasteride. Suggestions include trying dutasteride, hair systems, lifestyle changes, or considering a wig.
Managing blood pressure can help with hairloss, as seen with the use of medications like Cialis and oral minoxidil, which improved hairline and blood pressure. Lifestyle changes, such as reducing stimulant use and adjusting testosterone replacement therapy (TRT) doses, also play a role in addressing hairloss and overall health.
Dutasteride is more effective than Finasteride for hairloss, with similar safety profiles. Individual responses vary, and factors like Minoxidil use and age differences may influence results.
Scalp tension may contribute to hairloss by increasing DHT levels, with potential solutions like scalp massages and Botox. Concerns about finasteride's side effects were discussed, and some users shared personal experiences with alternative treatments like scalp massaging and Botox.
People are discussing JXL-069 (PP405) for hairloss, with some experimenting with a 0.05% topical gel. Concerns about safety and efficacy persist due to limited testing and lack of official approval.
Switching from finasteride to dutasteride for hairloss yields mixed results, with some users experiencing improvements and others facing worsening conditions or side effects like shedding. Patience is advised as dutasteride may take longer to show results, and combining treatments is suggested by some users.
Oral minoxidil is effective for hairloss but can cause cardiovascular side effects, such as pericardial effusion, especially in those with genetic predispositions. Starting with low doses and monitoring cardiovascular health are advised to reduce risks.
A user encouraged others experiencing hairloss to try shaving their heads, sharing their own positive experience despite briefly using finasteride and natural methods. Responses were mixed, with some supporting the decision and others suggesting treatments like minoxidil and finasteride, while many commented on the appearance changes.
Stopping minoxidil can lead to significant hairloss, but resuming it along with finasteride can help regain lost hair over time. Consistency is key for maintaining hair health and regrowth.
The post discusses using ketoconazole and finasteride for hairloss, suggesting waiting to use minoxidil. The user also mentions microneedling and emphasizes confidence over hair appearance.
The conversation is about a user's experience with finasteride not improving their hairloss and considering dutasteride as a last resort. Some users believe the user's hair appears stabilized, while others suggest surgery or patience, and one mentions heart issues as a reason for not using minoxidil.